Dermatomyositis and acute interstitial lung disease associated with MDA-5 antibodies: An atypical case

被引:13
|
作者
Girard, C. [1 ]
Vincent, T. [2 ]
Bessis, D. [1 ]
机构
[1] Univ Montpellier I, CHU, Hop St Eloi, Dept Dermatol, F-34295 Montpellier 5, France
[2] Univ Montpellier I, CHU, Hop St Eloi, Immunol Lab, F-34295 Montpellier 5, France
来源
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE | 2013年 / 140卷 / 10期
关键词
Dermatomyositis; MDA-5; antibodies; Interstitial lung disease; Acquired ichthyosis; JAPANESE PATIENTS; GENE; 5; JUVENILE DERMATOMYOSITIS; INFLAMMATORY MYOPATHIES; AUTOANTIBODIES; CALCINOSIS; ANTI-MDA5; CADM-140; FEATURES; PROTEIN;
D O I
10.1016/j.annder.2013.04.083
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background. - A new antibody known as anti-MDA-5 has recently been identified in association with a specific phenotype of dermatomyositis (DM), in which muscular involvement is minimal or absent, but where there is a particularly high risk of onset of aggressive interstitial lung disease. Below, we report a case associated with the presence of anti-MDA-5 antibodies complicated by aggressive interstitial lung disease; the cutaneous phenotype of this patient is novel due to the constitution of diffuse ichthyosis and of profuse subcutaneous calcinosis. Patients and methods. - A 35-year-old man was hospitalised for a skin rash associated with arthralgia, dry cough, asthenia and weight-loss of 8 kg in 5 months. The dermatological examination revealed purple erythema of the upper eyelids and cheeks, diffuse acquired ichthyosis of the trunk and limbs, and striated erythema on the proximal and distal metacarpal and interphalangeal joints of the fingers. A diagnosis of DM was suspected in patients treated with prednisolone, 1.5 mg/kg/d. Immunological tests identified the presence of anti-MDA-5 antibodies. One month later, the cutaneous signs continued to progress and were marked by the development of painful ulcers on the back of the fingers, as well as dyspnoea accompanying the slightest effort. Chest images showed constituted pulmonary fibrosis lesions. At the same time, within several months, diffuse, pseudo-tumoural calcifications developed in the subcutaneous tissue of the trunk and limbs. The patient was treated successively with intravenous gammaglobulins, cyclophosphamide, mycophenolate mofetil, azathioprine and rituximab in combination with oral corticosteroids, but with no improvement in respiratory function or in the skin lesions. Because of the decline in the patient's respiratory status, a lung graft was envisaged but subsequently abandoned because of the patient's excessively precarious state of health. Discussion. - Anti-MDA-5 antibody appears to constitute a specific immunological marker for a special dermatological phenotype of adult DM, significantly associated with the presence of: 1) keratotic papules in the skin folds of the palms and fingers; 2) cutaneous ulcers along the periungueal edges, Gottron's papules on the back of the hands and on the extensor surface of the elbows and knees; 3) pain and ulceration in the oral mucosa, diffuse alopecia, and appearance of "mechanic's hands" and Gottron's sign on the elbows and knees. To our knowledge, the presence of extensive ichthyosis and profuse subcutaneous calcinosis has not been previously reported in this particular form of DM. The risk of aggressive interstitial lung disease is particularly high and worsens the prognosis, since 40% of patients with anti-MDA-5 die, usually within the first year. Conclusion. Herein, we describe a patient presenting amyopathic DM complicated by aggressive interstitial lung disease associated with the presence of anti-MDA-5 antibodies, but with a hitherto unreported cutaneous phenotype combining diffuse ichthyosis and profuse subcutaneous calcinosis. (C) 2013 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:628 / 634
页数:7
相关论文
共 50 条
  • [31] Clinical features of dermatomyositis associated with anti-MDA5 antibodies by age
    Yamaguchi, Koichi
    Yamaguchi, Aya
    Onuki, Yuji
    Itai, Miki
    Kashiwagi, Chiharu
    Takehara, Kazutaka
    Aoki, Shuhei
    Kanaya, Azusa
    Taguchi, Kohei
    Umetsu, Kazue
    Oshima, Kazuma
    Uchida, Megumi
    Kimura, Hayato
    Kasahara, Morimitsu
    Takemura, Masao
    Hara, Kenichiro
    Sekiguchi, Akiko
    Motegi, Sei-ichiro
    Muro, Yoshinao
    Nakasatomi, Masao
    Motohashi, Rena
    Sakairi, Toru
    Nakagawa, Junichi
    Hiromura, Keiju
    Obokata, Masaru
    Kurabayashi, Masahiko
    Maeno, Toshitaka
    MODERN RHEUMATOLOGY, 2021, 31 (01) : 177 - 185
  • [32] Erythematous auricular papules in the fatal cases of anti-MDA5 antibody-positive interstitial lung disease
    Intapiboon, Porntip
    Siripaitoon, Boonjing
    RESPIRATORY MEDICINE CASE REPORTS, 2020, 31
  • [33] Tension Pneumomediastinum in Anti-MDA5 Antibody-positive Dermatomyositis-associated Interstitial Lung Disease: A Case Report and Literature Review
    Okabayashi, Hiroko
    Nakashima, Seiya
    Fujino, Kosuke
    Imai, Miyu
    Hamada, Shohei
    Masunaga, Aiko
    Ichiyasu, Hidenori
    Suzuki, Makoto
    Sakagami, Takuro
    INTERNAL MEDICINE, 2024, 63 (23) : 3221 - 3226
  • [34] Rapid increase of serum anti-MDA-5 antibodies and exacerbation of clinically amyopathic dermatomyositis/interstitial lung disease
    Murase, C.
    Muro, Y.
    Akiyama, M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 (01) : E43 - E44
  • [35] Risk Factors and Predictive Model for Dermatomyositis Associated with Rapidly Progressive Interstitial Lung Disease
    Wang, Kai
    Tian, Yian
    Liu, Shanshan
    Zhang, Zhongyuan
    Shen, Leilei
    Meng, Deqian
    Li, Ju
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2022, 15 : 775 - 783
  • [36] Early Initiation of Plasma Exchange Therapy for Anti-MDA5+Dermatomyositis with Refractory Rapidly Progressive Interstitial Lung Disease
    Sasaki, Noriko
    Nakagome, Yoko
    Kojima, Azusa
    Shimura, Keigo
    Ishii, Akira
    Sugiyama, Mai
    Izumi, Yuto
    Hirano, Kazuki
    Kurabayashi, Takayoshi
    Hosono, Yuji
    Yamada, Chiho
    Sato, Shinji
    INTERNAL MEDICINE, 2024, 63 (02) : 213 - 219
  • [37] Efficacy of plasma exchange in anti-MDA5-positive dermatomyositis with interstitial lung disease under combined immunosuppressive treatment
    Shirakashi, Mirei
    Nakashima, Ran
    Tsuji, Hideaki
    Tanizawa, Kiminobu
    Handa, Tomohiro
    Hosono, Yuji
    Akizuki, Shuji
    Murakami, Kosaku
    Hashimoto, Motomu
    Yoshifuji, Hajime
    Ohmura, Koichiro
    Mimori, Tsuneyo
    RHEUMATOLOGY, 2020, 59 (11) : 3284 - 3292
  • [38] Anti-MDA5 and anti-SSA/Ro52 antibodies double-positive dermatomyositis overlapping with rheumatoid arthritis-associated interstitial lung disease: A case report
    Xiong, Hong
    Tan, QianRen
    Luo, Feng
    Yuan, XueMei
    Ma, Wukai
    Yao, XueMing
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2022, 25 (12) : 1437 - 1440
  • [39] Mycophenolate mofetil for the patients with interstitial lung diseases in amyopathic dermatomyositis with anti-MDA-5 antibodies
    Hayashi, Masachika
    Kikuchi, Toshiaki
    Takada, Toshinori
    CLINICAL RHEUMATOLOGY, 2017, 36 (01) : 239 - 240
  • [40] Mycophenolate mofetil for the patients with interstitial lung diseases in amyopathic dermatomyositis with anti-MDA-5 antibodies
    Masachika Hayashi
    Toshiaki Kikuchi
    Toshinori Takada
    Clinical Rheumatology, 2017, 36 : 239 - 240